Group 1 - The FlexShares US Quality Large Cap Index Fund (QLC) has outperformed the SPDR S&P 500 ETF (SPY) over the last five years by focusing on quality, value, and momentum factors [1] - The Sunday Investor has developed a proprietary ETF Rankings system that evaluates nearly 1,000 ETFs based on various factors including costs, liquidity, risk, size, value, dividends, growth, quality, momentum, and sentiment [1] - The composite score from the ETF Rankings system ranges from 1 to 10, providing an easy-to-understand metric for investors [1] Group 2 - The Sunday Investor is actively engaged in the comments section of articles and encourages interaction with readers [1]

Market Performance & Sector Rotation - Healthcare sector is up 45%, materials are up 3%, and financials are up 25% this week [1] - 27 out of 30 new S&P 52-week highs are non-technology companies, indicating a shift in market momentum [1] - Momentum is turning towards quality assets, initially seen in the dollar, crypto, and gold [2][3] - A catch-up trade is occurring, with investors seeking growth opportunities in sectors like pharma and biotech due to tech being overbought [5] - The catch-up trade is expected to benefit small caps and the equal-weighted S&P, potentially narrowing the performance gap [6] Macroeconomic Factors & Risks - Potential government reopen may release delayed data, which could impact market sentiment and Fed policy [6][7] - Private labor data might indicate upcoming challenges, potentially influencing the Fed's decisions in December [7] - Volatility is expected to persist until the Fed's decision, with major events like Nvidia's report and the Fed decision on December 10th on the horizon [8][9] Healthcare Sector Analysis - Healthcare was unloved for most of the year, making it an attractive opportunity for investors seeking growth [5] - Rotation into healthcare is occurring, but the sector may contain landmines depending on specific investments [11] - Government spending cuts and insurance companies increasing margins could impact the healthcare sector [13] - Biotech is benefiting from lower rates, and healthcare is seen as a place to put money due to years of underperformance [14][15] - Some healthcare stocks have underperformed significantly, making new 12-month highs relatively easier to achieve [16] End-of-Year Outlook - The market is experiencing a chase for performance, with opportunities existing in areas beyond mega-cap tech [4][19] - The current rally is expected to continue until the end of the year, driven by the recognition of opportunities in other market areas [19] - The market is pausing in terms of upside, with volatility remaining a key factor until the Fed's decision [8]